FOY-305

DRUG2 trials

Sponsors

Ono Pharmaceutical Co. Ltd

Conditions

Healthy VolunteersSARS-CoV-2 Infection (COVID-19)

Phase 1

Multiple-dose Study of FOY-305 in Japanese Healthy Adult Male Subjects

CompletedNCT04451083

Ono Pharmaceutical Co. LtdHealthy Volunteers

Start: 2020-07-01End: 2020-08-17Updated: 2024-04-09

Phase 3

A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19)

CompletedNCT04657497

Ono Pharmaceutical Co. LtdSARS-CoV-2 Infection (COVID-19)

Start: 2020-11-09End: 2021-04-09Updated: 2024-04-05

Related Papers

A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study).

2022-09-2726 citations